BBIO · CIK 0001743881 · FY2025 live · 2025-12-31
BridgeBio Pharma, Inc.
View as
Model
Classic Z
FY2025
−6.79
Zone
Distress
Prior
—
Market DD
—
1y PD
—
−6.79
Z″ −14.22
Score −6.79 · distress below 1.80, grey to 2.99, safe at 3.00 and above.
Classic Z factor contributions
X1 Working capital / assets
Short-term liquidity versus the size of the balance sheet.
0.541.2 × = 0.65X2 Retained earnings / assets
Cushion from years of profits. Share buybacks can push this negative at otherwise healthy firms.
−4.081.4 × = −5.72X3 EBIT / assets
Operating return on assets. Highest weight in the original model.
−0.563.3 × = −1.85X4 Book equity / liabilities
Book equity versus the liability stack. Mega-caps often look greyer here than they would if X4 used market cap.
−0.690.6 × = −0.42X5 Sales / assets
Asset turnover — how much revenue the asset base supports.
0.541 × = 0.54
Five-year path
Need two annual 10-Ks to draw a path. The desk will pull this issuer’s filings rather than invent a series.
Overview
rule-v1
BridgeBio Pharma, Inc. is on classic Z at −6.79 (distress) for FY2025, from an SEC 10-K. Retained earnings / assets is the line that sets the print. This is the first live year on the desk. No market tape loaded. Classic Z was fit on manufacturers; buybacks can send retained earnings negative at otherwise healthy issuers, and X4 is book equity, not market cap.
Book screen Distress; market PD —. Tape not priced — not a single default call.
Market DD · naive Merton
No market tape yet.
Pull a year of closes (Yahoo, Nasdaq if Yahoo is limited) and size equity from Nasdaq cap or EDGAR shares. Distance-to-default and 1-year PD stay blank until then.
Sector peers
Closest Classic Z scores · 23rd percentile in Healthcare.
- SLNDistressSilence Therapeutics plc−6.77
- LRMRDistressLarimar Therapeutics, Inc.−6.75
- VANIDistressVivani Medical, Inc.−6.84
- ABOSDistressAcumen Pharmaceuticals, Inc.−6.71
- CGTXDistressCOGNITION THERAPEUTICS INC−6.71
- NEUPDistressNeuphoria Therapeutics Inc.−6.67
- LYELDistressLyell Immunopharma, Inc.−6.91
- FLNADistressFILANA THERAPEUTICS, INC.−6.97
KPI widgets
Current assets
$798M
Total assets
$936M
Current liabilities
$288M
Total liabilities
$3.0B
Working capital
$510M
Retained earnings
−$3.8B
EBIT
−$523M
Total sales
$502M
Book equity
−$2.1B
Accession 0001743881-26-000009. Live rank is the latest 10-K on EDGAR (FY2025, period 2025-12-31). Classic Z is the live score. View as does not rewrite the live rank. X4 is book equity. Pulled 12 Sept 2026.